Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
Thursday, April 16, 2026 at 12:05 AM · By Pam Belluck
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.